Elif Gur Kabul¹, Pervin Demir2, Firdevs Ulutas3, Sinem Yenil4, Bilge Basakci Calik4, Veli Cobankara3
1.Faculty of Health Sciences, Physiotherapy and Rehabilitation, Usak University, Usak, Turkey
2.Department of Biostatistics and Medical Informatics, Ankara Yıldırım Beyazıt University, Ankara, Turkey
3.Department of Rheumatology, Medical Faculty, Pamukkale University, Denizli, Turkey
4.Faculty of Physiotherapy and Rehabilitation, Pamukkale University, Denizli, Turkey
*Corresponding Author: Elif Gur Kabul; E-mail: elifgur1988@hotmail.com
Abstract
Objective
This study aimed to examine the validity and reliability of Turkish version of Brief Fear of Negative Evaluation Scale–Straightforwardly (BFNE-S (TR)) in patients with Systemic Sclerosis (SSc).
Materials and Methods
35 individuals (mean age: 53.3±13.0 years) diagnosed as SSc were included. Data on demographics, were collected via structured interview. All participants were evaluated by same investigator. The disability was evaluated with Scleroderma Health Assessment Questionnaire (SHAQ), disease severity with Medsger’s Disease Severity Scale, and skin involvement with Modified Rodnan Skin Score. BFNE-S (TR) was applied to the patients with SSc who did not receive any treatment for test retest at one-week intervals.
Results
The one-factor structure was provided for all indices except Chi-Square. Factor loadings were significant. The patient responses to the BFNE-S (TR) demonstrated excellent internal consistency (Cronbach’s α: 0.95). The floor effect (20%) percentage of patients who scored at floor level, was observed. Test-retest reliability of the scale was excellent with 0.91 (95%CI: 0.78–0.96). BFNE-S (TR) total score had positive correlation with SHAQ_Digestive (r=0.503) and SHAQ_Raynaud phenomenon (r=0.343)(p<0.05).
Conclusions
The BFNE-S (TR) is a reliable and valid scale and can be used for measurement of fear of negative evaluation in SSc.
Key words: Systemic Sclerosis, fear, questionnaire, disease severity, skin disease.